About Acute myeloblastic leukemia with maturation
Acute myeloblastic leukemia with maturation is a rare disease catalogued by Orphanet (ORPHA:98834). It is associated with the FLT3, KIT, NPM1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Acute myeloblastic leukemia with maturation trials.
Search ClinicalTrials.gov for "Acute myeloblastic leukemia with maturation" or filter by Orphanet code ORPHA:98834 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Acute myeloblastic leukemia with maturation trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Acute myeloblastic leukemia with maturation. Updated daily.